Cvs Health (CVS) Asset Writedowns and Impairment (2022 - 2024)

Cvs Health has reported Asset Writedowns and Impairment for 3 years, with the latest figure at -$840.0 million in Q4 2024.

• For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$840.0 million; the trailing twelve-month figure through Dec 2024 stood at -$233.0 million (down 164.54% YoY), and the FY2023 full-year result was $152.0 million, down 94.0% from the prior year.
• Asset Writedowns and Impairment for Q4 2024 stood at -$840.0 million, down from $607.0 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $2.5 billion in Q3 2022, with the low at -$840.0 million in Q4 2024.
• Historically, Asset Writedowns and Impairment has averaged $441.5 million across 3 years, with a median of $195.0 million in 2022.
• The largest YoY upside for Asset Writedowns and Impairment was 751.22% in 2023 against a maximum downside of 751.22% in 2023.
• Cvs Health's Asset Writedowns and Impairment stood at $12.0 million in 2022, then jumped by 2808.33% to $349.0 million in 2023, then sank by 340.69% to -$840.0 million in 2024.
• The last three Asset Writedowns and Impairment figures came in at -$840.0 million (Q4 2024), $607.0 million (Q3 2024), and $349.0 million (Q1 2023), per Business Quant data.